Moreover, the main markers in peripheral blood, namely, levels of mMDSCs, were also important indicators of survival in breast cancer as well as melanoma, and a combination of mMDSC levels and her2-reactivity even more so (32), as was the level of circulating plasmacytoid dendritic cells (34). This evidence concerns the gene ERBB2 and breast cancer.